Komori
Astellas Pharma (4503) · RiskRestated

Actuarial Risks in Defined Benefit Plans

First written in FY2019. 8 of 9 entries say "Restated". Latest entry: FY2024-Q3.

9entries
6years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2019 – FY2024-Q32019: 120192020: 220202021: 320212022: 120222023: 120232024: 1
Same theme, other companies
Risk of Changes in Actuarial Assumptions for Retirement Benefit ObligationsA theme 172 companies write about · 172 as a headwind · 0 as a tailwind

87 other companies' latest entry also says "Restated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 172 companies compared. The sentences above are computed from all 172.
Full recordFilings, disclosures and news, newest first
  1. FY2024-Q3RestatedAnnual report

    「During the nine-month cumulative period, there were no new business or other risks, nor any material changes to the business or other risks described in the securities report for the previous fiscal year.」

    確定給付制度の数理計算上のリスクを含む既存の事業等のリスクについて、重要な変更がないと再確認している。
  2. FY2024-Q1RestatedAnnual report

    「During the three-month cumulative period, there were no new business or other risks, nor any material changes to the business or other risks described in the securities report for the previous fiscal year.」

    確定給付制度の数理計算上のリスクを含む既存の事業等のリスクについて、重要な変更がないと再確認している。
  3. FY2022-Q3RestatedAnnual report

    「During the nine-month period ended [the current third quarter], there were no newly arising business or other risks, nor any material changes to the business and other risks described in the Annual Securities Report for the prior fiscal year.」

    確定給付制度の数理計算上のリスクを含む既存の事業等のリスクについて、重要な変更がないと再確認している。
  4. FY2022-Q2RestatedAnnual report

    「During the six-month period ended [the current second quarter], there were no newly arising business or other risks, nor any material changes to the business and other risks described in the Annual Securities Report for the prior fiscal year.」

    確定給付制度の数理計算上のリスクを含む既存の事業等のリスクについて、重要な変更がないと再確認している。
  5. FY2022-Q1RestatedAnnual report

    「During the three-month period ended [the current first quarter], there were no newly arising business or other risks, nor any material changes to the business and other risks described in the Annual Securities Report for the prior fiscal year.」

    確定給付制度の数理計算上のリスクを含む既存の事業等のリスクについて、重要な変更がないと再確認している。quantified/materializedは本引用上は該当しない。
  6. FY2021-Q3RestatedAnnual report

    「During the nine-month period ended [the current third quarter], there were no newly arising business or other risks, nor any material changes to the business and other risks described in the Annual Securities Report for the prior fiscal year.」

    確定給付制度の数理計算上のリスクを含む既存の事業等のリスクについて、重要な変更がないと再確認している。
  7. FY2021-Q1RestatedAnnual report

    「During the three-month period ended [the current first quarter], there were no newly arising business or other risks, nor any material changes to the business and other risks described in the Annual Securities Report for the prior fiscal year.」

    確定給付制度の数理計算上のリスクを含む既存の事業等のリスクについて、重要な変更がないと再確認している。
  8. FY2020-Q3RestatedAnnual report

    「There were no newly arising business or other risks during the cumulative third-quarter period, and no material changes to the business or other risks described in the securities report for the previous fiscal year.」

    確定給付制度の数理計算上のリスクを含む既存の事業等のリスクについて、重要な変更がないと再確認している。
  9. FY2019First statedAnnual report

    「確定給付型の退職給付制度は、数理計算上のリスクに晒されています。」

    確定給付制度の数理計算上のリスクを明示し、割引率が0.5%変動した場合に確定給付制度債務が113億11百万円減少又は132億65百万円増加する感応度を開示している。
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
Astellas Pharma's next results are scheduled for 2026-11-04. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.